Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts ; volume:16 ; number:1 ; day:22 ; month:7 ; year:2024 ; pages:1-13 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (22.7.2024), 1-13, 12.2024
- Urheber
-
Wang, Yi-Ting
Therriault, Joseph
Tissot, Cécile
Servaes, Stijn
Rahmouni, Nesrine
Macedo, Arthur Cassa
Fernandez-Arias, Jaime
Mathotaarachchi, Sulantha S.
Stevenson, Jenna
Lussier, Firoza Z.
Benedet, Andréa L.
Pascoal, Tharick A.
Ashton, Nicholas J.
Zetterberg, Henrik
Blennow, Kaj
Gauthier, Serge
Rosa-Neto, Pedro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-024-01509-5
- URN
-
urn:nbn:de:101:1-2410072059371.866208151535
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Yi-Ting
- Therriault, Joseph
- Tissot, Cécile
- Servaes, Stijn
- Rahmouni, Nesrine
- Macedo, Arthur Cassa
- Fernandez-Arias, Jaime
- Mathotaarachchi, Sulantha S.
- Stevenson, Jenna
- Lussier, Firoza Z.
- Benedet, Andréa L.
- Pascoal, Tharick A.
- Ashton, Nicholas J.
- Zetterberg, Henrik
- Blennow, Kaj
- Gauthier, Serge
- Rosa-Neto, Pedro
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial
Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial
Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial